This review of the literature on late rectal complications after prostate brachytherapy indicated that it is a highly effective treatment modality for patients with clinically localized …
NN Stone, L Potters, BJ Davis, JP Ciezki… - International Journal of …, 2009 - Elsevier
PURPOSE: To investigate the biochemical control rates and survival for Gleason score 7–10 prostate cancer patients undergoing permanent prostate brachytherapy as a function of the …
AS Taggar, T Charas, NC Gil'ad, K Boonyawan… - Brachytherapy, 2018 - Elsevier
Purpose Rates of rectal toxicity after low-dose-rate (LDR) brachytherapy for prostate cancer are dependent on rectal dose, which is associated with rectal distance from prostate and …
LA Dawson, C Ménard - The oncologist, 2010 - academic.oup.com
An inherent goal of radiation therapy is to deliver enough dose to the tumor to eradicate all cancer cells or to palliate symptoms, while avoiding normal tissue injury. Imaging for cancer …
Purpose Education and training on prostate brachytherapy for radiation oncology and medical physics residents in the United States is inadequate, resulting in fewer competent …
F Moltzahn, A Dal Pra, M Furrer… - … and clinical urology, 2016 - synapse.koreamed.org
Urethral stricture after radiation therapy for localized prostate cancer is a delicate problem as the decreased availability of tissue healing and the close relation to the sphincter …
MA Moerland, MJH van Deursen, SG Elias… - Radiotherapy and …, 2009 - Elsevier
BACKGROUND AND PURPOSE: In permanent prostate brachytherapy the dose distributions 4 weeks post implant differ from the intraoperative dose distributions. The …
N Tanaka, I Asakawa, S Anai, A Hirayama… - Radiation …, 2013 - Springer
Background To compare the periodical incidence rates of genitourinary (GU) and gastrointestinal (GI) toxicity in patients who underwent prostate low-dose-rate brachytherapy …
T Zilli, D Taussky, D Donath, HP Le… - International Journal of …, 2011 - Elsevier
PURPOSE: To report the toxicity outcome in patients with localized prostate cancer undergoing 125I permanent-seed brachytherapy (BT) according to a urethra-sparing …